Viewing Study NCT01072357

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2026-01-24 @ 8:26 PM
Study NCT ID: NCT01072357
Status: COMPLETED
Last Update Posted: 2018-06-15
First Post: 2010-02-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Sponsor: Reza Dana, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Corneal Neovascularization View
None Corneal Graft Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-Risk Corneal Transplantation View
None Penetrating Keratoplasty View
None Neovascularization View
None Corneal Blood Vessels View
None Avastin View
None Bevacizumab View
None Corneal Graft View